Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-28

Clinical Trial Update: Benefits of a Cannabidiolic Acid Topical Cream for the Treatment of Restless Leg Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating a cannabidiolic acid topical cream for Restless Legs Syndrome; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabidiolic acid topical cream (cannabidiolic acid)

Snippet

Sponsor: Synthonics Inc | Conditions: Restless Legs Syndrome | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING